Grover’s disease — current understanding of transient and persistent acantholytic dermatosis
- Authors: Chepushtanova K.O.1, Patrushev A.V.1, Gorbunov Y.G.1, Belousova I.E.1
-
Affiliations:
- S.M. Kirov Military Medical Academy
- Issue: Vol 100, No 3 (2024)
- Pages: 17-25
- Section: REVIEWS
- URL: https://ogarev-online.ru/0042-4609/article/view/262334
- DOI: https://doi.org/10.25208/vdv16048
- ID: 262334
Cite item
Full Text
Abstract
Grover’s disease is a papulo-vesicular pruritic dermatosis characterized by a transient, persistent, or asymptomatic course. We have analyzed the publications found in the PubMed and RSCI scientific literature databases between 1970 and 2022. The clinical manifestations of Grover’s disease, possible localization, etiological factors, and the histological and dermatoscopic picture of the disease are described. According to the literature, the putative associations with disease onset are highly variable and include insolation, pregnancy, hemodialysis, chemotherapy, sweating, a number of dermatoses, and a history of malignancy and organ transplantation. Seasonality of the process has also been described. To date, nine histologic patterns of the disease have been described, the most common being acantholytic dyskeratosis.
Full Text
##article.viewOnOriginalSite##About the authors
Kseniya O. Chepushtanova
S.M. Kirov Military Medical Academy
Author for correspondence.
Email: kseniyachepushtanova@mail.ru
ORCID iD: 0000-0001-6883-0762
SPIN-code: 5037-7208
Russian Federation, Saint Petersburg
Aleksandr V. Patrushev
S.M. Kirov Military Medical Academy
Email: alexpat2@yandex.ru
ORCID iD: 0000-0002-6989-9363
SPIN-code: 1367-5580
MD, Dr. Sci. (Med.)
Russian Federation, Saint PetersburgYuri G. Gorbunov
S.M. Kirov Military Medical Academy
Email: urikgor@rambler.ru
ORCID iD: 0000-0002-1375-056X
SPIN-code: 3393-3256
MD, Cand. Sci. (Med.)
Russian Federation, Saint PetersburgIrena E. Belousova
S.M. Kirov Military Medical Academy
Email: irena.belousova@mail.ru
ORCID iD: 0000-0002-9458-0872
SPIN-code: 2287-5062
MD, Dr. Sci. (Med.), Professor
Russian Federation, Saint PetersburgReferences
- Grover RW. Transient acantholytic dermatosis. Arch Dermatol. 1970;101(4):426–434.
- Chalet M, Grover R, Ackerman AB. Transient acantholytic dermatosis: a reevaluation. Arch Dermatol. 1977;113(4):431–435.
- Fernández-Figueras MT, Puig L, Cannata P, Cuatrecases M, Quer A, Ferrándiz C, et al. Grover disease: a reappraisal of histopathological diagnostic criteria in 120 cases. Am J Dermatopathol. 2010;32(6):541–549. doi: 10.1097/DAD.0b013e3181c80cf9
- Parsons JM. Transient acantholytic dermatosis (Grover’s disease): a global perspective. J Am Acad Dermatol. 1996;35(5 Pt 1):653–666. doi: 10.1016/s0190-9622(96)90715-x
- Simon RS, Bloom D, Ackerman AB. Persistent acantholytic dermatosis: a variant of transient acantholytic dermatosis (Grover disease). Arch Dermatol. 1976;112(10):1429–1431. doi: 10.1001/archderm.112.10.1429
- Quirk CJ, Heenan PJ. Grover’s disease: 34 years on. Australas J Dermatol. 2004;45(2):83–86. doi: 10.1111/j.1440-0960.2004.054_1.x
- Gantz M, Butler D, Goldberg M, Ryu J, McCalmont T, Shinkai K. Atypical features and systemic associations in extensive cases of Grover disease: A systematic review. J Am Acad Dermatol. 2017;77(5):952–957.e1. doi: 10.1016/j.jaad.2017.06.041
- Davis MD, Dinneen AM, Landa N, Gibson LE. Grover’s disease: clinicopathologic review of 72 cases. Mayo Clin Proc. 1999;74(3):229–234. doi: 10.4065/74.3.229
- Grover RW, Rosenbaum R. The association of transient acantholytic dermatosis with other skin diseases. J Am Acad Dermatol. 1984;11(2 Pt 1): 253–256. doi: 10.1016/s0190-9622(84)70160-5
- Scheinfeld N, Mones J. Seasonal variation of transient acantholytic dyskeratosis (Grover’s disease). J Am Acad Dermatol. 2006;55(2):263–268. doi: 10.1016/j.jaad.2006.01.029
- Fernández-Figueras MT. Dermatopathology of COVID-19 infection and vaccination. Pathologie (Heidelb). 2022;43(Suppl 1):114–118. doi: 10.1007/s00292-022-01126-9
- Rongioletti F, Ferreli C, Sena P, Caputo V, Atzori L. Clinicopathologic correlations of COVID-19-related cutaneous manifestations with special emphasis on histopathologic patterns. Clin Dermatol. 2021;39(1):149–162. doi: 10.1016/j.clindermatol.2020.12.004
- Llamas-Velasco M, Chicharro P, Rodríguez-Jiménez P, Martos-Cabrera L, De Argila D, Fernández-Figueras M, et al. Comment on “Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital”. Pseudoherpetic Grover disease seems to occur in patients with COVID-19 infection. Clin Exp Dermatol. 2020;45(7):896–898. doi: 10.1111/ced.14305
- Giavedoni P, Podlipnik S, Pericàs JM, Fuertes de Vega I, García-Herrera A, Alós L, et al. Skin Manifestations in COVID-19: Prevalence and Relationship with Disease Severity. J Clin Med. 2020;9(10):3261. doi: 10.3390/jcm9103261
- Phillips C, Kalantari-Dehaghi M, Marchenko S, Chernyavsky AI, Galitovskiy V, Gindi V, et al. Is Grover’s disease an autoimmune dermatosis? Exp Dermatol. 2013;22(12):781–784. doi: 10.1111/exd.12266
- Melwani PM, Parsons AC, Sangueza OP. Early histopathologic changes in grover disease. Am J Dermatopathol. 2010;32(6):565–567. doi: 10.1097/DAD.0b013e3181cb3fbe
- Errichetti E, De Francesco V, Pegolo E, Stinco G. Dermoscopy of Grover’s disease: Variability according to histological subtype. J Dermatol. 2016;43(8):937–939. doi: 10.1111/1346-8138.13298
- De Abreu L, Cordeiro NG, Buçard AM, Quintella DC, Argenziano G. Dermoscopy of Grover disease. J Am Acad Dermatol. 2017;76(2S1):S60–S63. doi: 10.1016/j.jaad.2016.07.031
- Wang Q, Luo N, Lei M, Chen X, Li C, Hao P. Bullous Grover’s Disease in a Chinese Tibetan Adolescent: A Case Report. Clin Cosmet Investig Dermatol. 2022;15:1371–1376. doi: 10.2147/CCID.S373228
- Lee EH, Lee SE, Kim YC, Kim SC. Grover’s disease associated with pregnancy. J Dermatol. 2010;37(4):381–383. doi: 10.1111/j.1346-8138.2010.00821.x
- Карачева Ю.В., Смыкова А.Н., Волошин В.В. Болезнь Гровера. Российский журнал кожных и венерических болезней. 2016;19(4):231–233. [Karacheva UV, Smykova AN, Voloshin VV. Grover’s disease. Rossiiskii zhurnal kozhnykh i venericheskikh boleznei. 2016;19(4):231–233. (In Russ.)] doi: 10.18821/1560-9588-2016-19-4-231-233
- Helfman RJ. Grover’s disease treated with isotretinoin. Report of four cases. J Am Acad Dermatol. 1985;12(6):981–984. doi: 10.1016/s0190-9622(85)70124-7
- Kouba DJ, Dasgeb B, Deng AC, Gaspari AA. Effective treatment of persistent Grover’s disease with trichloroacetic acid peeling. Dermatol Surg. 2006;32(8):1083–1088. doi: 10.1111/j.1524-4725.2006.32233.x
- Barei F, Torretta S, Morini N, Ferrucci S. A case of Grover disease treated with Dupilumab: Just serendipity or a future perspective? Dermatol Ther. 2022;35(5):e15429. doi: 10.1111/dth.15429
- Renz P, Hasan S, English JC, Wegner RE, Jedrych J, Ho J, et al. Grover’s Disease Treated with Total Skin Electron Beam Radiotherapy. J Drugs Dermatol. 2019;18(4):392–393.
- Sousou JM, Fritsche JM, Fernandez BR, Tummala MR, Scott R. Management and Treatment of Grover’s Disease: A Case Report and Review of Literature. Cureus. 2022;14(4):e24082. doi: 10.7759/cureus.24082
Supplementary files
